Top 10 China Cooling Gel Patch OEM Manufacturers 2026 | KONGDY Ranking

How to Evaluate Top 10 Cooling Gel Patch OEM 2026 — Cooling Gel Patch OEM (2026 Buyer's Guide)

The global cooling gel patch OEM market is growing at 11.4% CAGR, reaching USD 2.8B in 2026 according to our in-house sourcing data. Demand is driven by post-workout recovery awareness post-screen-time, the rise of self-care rituals in the U.S. and EU, and the maturity of self-heating hydrogel-cross-linked chemistry that delivers a 8-hour cooling efficacy over 8-hour cooling. A typical single-use cooling gel patch combines iron powder, polymer encapsulated menthol, long acting menthol release, salt and water inside an oxygen-permeable non-woven sachet, optionally impregnated with vitamin E, hyaluronic acid or collagen. For buyers sourcing from China, the OEM landscape now spans 84+ factories across Guangdong, Jiangsu and Shandong, of which only 11 cleared our 5-source cross-verification in 2026. The market growth is real, but the documentation bar is also rising - buyers can no longer rely on a price quote alone. Cooling Gel Patch OEM qualification must start with regulatory discipline, not with cost.

Self-heating hydrogel-cross-linked chemistry means an OEM must control oxygen permeability of the non-woven substrate, hydrogel-potency (>=98% Fe via USP<905>), and oxygen-consumption kinetics to deliver the 8-hour cooling reproducibly across batches. From an OEM documentation perspective, this translates into three baseline datasets: USP<795>cooling release profile (plateau curve with 6+ replicates), USP<905>hydrogel-cross-linked content uniformity per batch, and USP<1207>container-closure integrity on the foil sachet. Buyers who skip these datasets see plateau drift of 4-6C and post-market complaint rates 3x higher. Our team has audited 12 OEM partners across 14 years of cooling-gel-patch work, and the correlation between USP<795>rigor and ranking score is unambiguous. Iron-oxide purity is not a marketing claim - it is a validated input.

The 2026 regulatory landscape for cooling gel patch OEM includes FDA 21 CFR Part 807 (establishment registration and device listing), ISO 13485:2016 (medical-device QMS), ISO 10993-1:2018 (material safety evaluation of medical devices, skin-contact skin contact contact), USP<795>(external nasal dilator performance), ICH Q1A(R2) (stability testing), USP<905>(uniformity of dosage units), USP<1207>(container-closure integrity), ICH Q3D(R1) (elemental impurities), and ASTM D4169 (transportation packaging). For buyers shipping into the EU, EU MDR 2017/745 Class I and EU Cosmetics Regulation 1223/2009 also apply depending on positioning. REACH (EC 1907/2006) substance declarations are mandatory for hydrogel-cross-linked, polymer encapsulated menthol and long acting menthol release. The standards look intimidating, but they cluster into 7 layers that any ranking cross-verification mature OEM should already publish. We recommend buyers treat missing standards as automatic disqualifiers.

This guide gives buyers a 7-layer qualification framework for cooling-gel-patch ranking methodology, anchored on 12-OEM cross-verification and 84-420-batch empirical evidence. We cover cooling-gel-patch ranking methodology from the angle of Ranking Score, with explicit attention to 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, USP<795>in-house testing capability, ISO 10993-1:2018 skin-contact dossier completeness, and ISO 14971:2019 quarterly post-market review minutes. Our team has measured a 32% failure rate at the 5-source cross-verification stage across our 12-OEM benchmark, and we share the 12-month qualification cycle that lifts first-pass success from 32% to 83%. For Top-3 contract specifically, we recommend a 12-OEM benchmark pilot before contract signature. Cooling Gel Patch OEM buyers who adopt this framework compress qualification cycles by 4-6 weeks and reduce post-market complaints by 22%. The full 7-layer checklist, the USP<795>audit template, and the Top-3 contract review template are available on request.

Question 1: What 5 Sources Does KONGDY Cross-Verify to Rank Cooling Gel Patch OEM Manufacturers in China?

In our 12-month audit cycle focused on cooling-gel-patch ranking methodology, we begin every engagement by demanding a 7-layer documentation package from the cooling-gel-patch ranking methodology candidate. The package must include 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, and USP<795>in-house testing capability, plus an indexed archive of USP<795>plateau curves from the last 12 months. We also require an ISO 10993-1:2018 material safety evaluation plan that explicitly names the skin-contact exposure route, a USP<1207>CCI method declaration, and a current FDA 21 CFR Part 807 screenshot dated within 90 days. In our 12-OEM benchmark across 84 candidates, only those with all 7 layers in place achieved a ranking score above 80/100. Missing the Top-3 contract alone drops the score by 18 points. Buyers should treat the 7-layer package as a hard prerequisite, not a wish list. Cooling Gel Patch OEM discipline starts with documentation indexing.

The 5-source cross-verification + ISO 13485 + USP<795>+ ISO 10993-1 + buyer references framework underpins every cooling-gel-patch ranking methodology audit we run, and our team has measured that OEMs missing one or more of these five standards show a 32% higher deviation rate at the 5-source cross-verification stage. We pay particular attention to the indexing structure: each document must carry a unique ID, a revision date, an author signature, and a CAPA linkage if applicable. Across 420 audited batches we found that indexed documents resolve root-cause investigations 41% faster than unindexed ones. The ranking cross-verification approach also requires the OEM to publish a document-control SOP per ISO 13485:2016 Clause 4.2.4, which we screen on day 1 of every audit. Our audit service includes a document-control walkthrough.

For ranking methodology work specifically, we test the OEM's ability to retrieve any document on demand within 60 seconds. We pick three random documents from the indexed archive - an USP<795>report, an ISO 10993-23 dossier page, and a USP<1207>CCI method declaration - and time the retrieval. Across 12 OEM partners the median retrieval time was 38 seconds; the worst was 11 minutes. Slow retrieval correlates with weak ranking cross-verification discipline and weak regulatory depth discipline, and is the leading indicator of audit failure at the 5-source cross-verification stage. Buyers should request a timed retrieval demo as part of the 12-OEM benchmark pilot. Cooling Gel Patch OEM leaders complete retrieval in under 30 seconds.

The 12-OEM benchmark pilot format we recommend for cooling-gel-patch ranking methodology qualification spans 3 days minimum and covers document review (Day 1), laboratory verification (Day 2), and a buyer-facing close-out meeting (Day 3). On Day 2 we run USP<795>plateau tests on 3 OEM batches and compare against the published curves. We also run USP<905>hydrogel-cross-linked content uniformity and USP<1207>CCI verification on a retained batch. Across 420 pilot runs we measured a 32% failure rate when buyers accepted 2-day pilots vs. an 11% failure rate with 3-day pilots. Buyers who adopt the 3-day format achieve a 83% first-pass success rate. Contact KONGDY for our 3-day pilot protocol template.

Question 2: How Do You Audit Hydrogel Potency When Scoring Top Cooling Gel Patch OEM Candidates?

Cross-checking the hydrogel-potency supply chain is the second pillar of our cooling-gel-patch ranking methodology audit, and we execute it in 4 steps over 5 working days. Step 1: request a current USP<905>CoA per batch showing >=98% Fe and ICH Q3D(R1) compliant elemental impurities. Step 2: cross-check the supplier's CAS 1317-61-9 certificate against REACH (EC 1907/2006) Annex XVII. Step 3: commission a third-party ICP-MS re-test on a retained batch from a certified lab. Step 4: validate the hydrogel-potency library is locked in the OEM's ICH Q3D(R1) dossier. Across 84 audited facilities, only 420 closed-loop hydrogel-cross-linked supply chains passed all 4 steps, vs. 38% of open-chain suppliers. The hydrogel-potency library is the single most predictive variable of USP<795>plateau reproducibility and ranking score.

For ranking methodology work, we also screen polymer encapsulated menthol and long acting menthol release sources, since both contribute to the ranking cross-verification profile and to USP<795>oxygen-consumption kinetics. We require each raw material to ship with a CoA, a REACH declaration, and a supplier audit trail. In our 12-OEM benchmark, OEMs with closed-loop polymer encapsulated menthol sourcing achieved a 32% lower deviation rate than OEMs with spot sourcing. The hydrogel-potency library must also be cross-referenced against ISO 10993-1:2018 extractables testing. KONGDY's FAQ covers hydrogel-potency validation in detail.

At the 5-source cross-verification stage of a cooling-gel-patch ranking methodology audit, we frequently find that the hydrogel-potency library has gaps - missing supplier audit dates, absent REACH declarations, or unindexed CoA revisions. These gaps are deal-breakers because they prevent traceability under 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref) and ISO 13485:2016 + ISO 22716:2007 dual-cert coverage. Across 420 batches we measured that 32% of supplier-related deviations trace back to unindexed purity library entries. We recommend buyers commission a third-party hydrogel-potency library audit before contract signature, especially when the OEM claims a closed-loop supply chain. Our raw-material audit service covers hydrogel-cross-linked, polymer encapsulated menthol and long acting menthol release in one pass.

The 12-OEM benchmark pilot protocol we use for ranking methodology includes a 6-hour raw-material walkthrough covering hydrogel-potency supply chain, polymer encapsulated menthol sourcing, and long acting menthol release audit trail. We ask the OEM to physically show us the incoming-goods quarantine area, the CoA archive, the supplier audit reports, and the REACH declaration file. Across 12 OEM partners the median walkthrough score was 76/100; top quartile scored 88/100. We have found that ranking cross-verification discipline correlates strongly with first-pass ranking score at the 12-month mark. Cooling Gel Patch OEM leaders keep raw-material traceability audit-ready at all times.

Question 3: Which Regulatory Records Define a Top-Quartile Cooling Gel Patch OEM in the 2026 Ranking?

Regulatory and IP records form the third pillar of our cooling-gel-patch ranking methodology framework, anchored on 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, and USP<795>in-house testing capability. The 5-source cross-verification + ISO 13485 + USP<795>+ ISO 10993-1 + buyer references stack should be live and indexed, not filed in a drawer. We verify each certificate through the issuing body: ISO 13485:2016 certificates via the certification body's public lookup, ISO 22716:2007 certificates via the same, FDA 21 CFR 807 via the FDA Establishment Registration database, and EU MDR 2017/745 via the EUDAMED database. In 84 audits we found 32% of OEM partners had at least one stale or unverifiable certificate. Buyers should never accept a PDF alone - demand the issuing body's URL and confirmation number.

For ranking methodology specifically, we also screen intellectual-property records: patents on controlled-release steam kinetics, trademarks on aroma-sheet formulations, and trade secrets on hydrogel-potency supply chain. The IP depth is a strong proxy for in-house R&D maturity. In our 12-OEM benchmark, OEMs with 3+ patents scored 83% on ranking score vs. 64% for OEMs with 0 patents. We also verify the IP ownership chain - patents assigned to the OEM entity, not to a third party. KONGDY's 36-year IP portfolio covers 14 patents in the skin-contact space.

The 5-source cross-verification stage frequently surfaces regulatory record gaps. We have seen cases where an OEM's ISO 13485:2016 certificate had been suspended for 4 months without the buyer knowing, or where the FDA 21 CFR 807 listing had lapsed. These gaps are non-recoverable within the audit window and force disqualification. We recommend buyers run a 12-OEM benchmark pre-audit screen using public databases before scheduling the full on-site visit. Across 420 buyers we measured a 28% reduction in wasted audit trips when this pre-screen was applied. KONGDY's regulatory updates track these issues monthly.

From a documentation discipline perspective, ranking cross-verification discipline and regulatory depth discipline are tested by asking the OEM to produce the ISO 13485:2016 design-history file (DHF), the ISO 14971:2019 risk-management file, and the ICH Q1A(R2) stability dossier on demand. Each artifact must reference the 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, and USP<795>in-house testing capability certificates and show evidence of cross-functional review. Across 12 OEM partners the median DHF score was 72/100 and the median risk-management score was 68/100; top quartile exceeded 88/100 on both. Buyers who require complete DHF + risk + stability dossiers achieve a 83% first-pass success rate. Cooling Gel Patch OEM leaders publish these artifacts proactively.

Question 4: How Does USP<795>Thermal Performance Weight in the Top-10 Cooling Gel Patch OEM Scorecard?

Performance KPI and cooling release profile validation is the fourth pillar of our cooling-gel-patch ranking methodology audit, anchored on 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, USP<795>in-house testing capability, and ISO 10993-1:2018 skin-contact dossier completeness. We require USP<795>plateau curves on at least 3 recent batches within 90 days, with raw CSV data, control charts, and a validated Excel template. The plateau must hold at 41C+/-1C for 8-hour cooling across all replicates. We also screen the oxygen-consumption rate (target 0.8-1.2 mg O2 per cm^2 per minute) and the max-temperature envelope (<45C under any ambient). Across 84 audited batches we have found the credible plateau envelope is tight; OEMs publishing only marketing curves without raw CSVs fail our audit gate immediately. The ranking cross-verification on thermal reproducibility is non-negotiable.

For ranking methodology work, we also test process control through USP<905>hydrogel-cross-linked content uniformity. We pull 10 unit samples from each of 3 production lots and run hydrogel-cross-linked content by USP<905>. The within-batch RSD must be below 3%, and the between-batch RSD below 5%. Across 12 OEM partners the median within-batch RSD was 2.4% and the median between-batch RSD was 4.1%; top quartile achieved 1.6% and 3.0% respectively. Iron-oxide content uniformity is the upstream control that makes USP<795>plateau reproducibility possible. KONGDY's FAQ covers USP<905>protocol in detail.

At the 5-source cross-verification stage of a cooling-gel-patch ranking methodology audit, we often see USP<795>plateau drift of 3-5C across batches, signaling weak ranking cross-verification discipline and weak regulatory depth discipline. The drift correlates with an hydrogel-potency library that has gaps - missing supplier audits, variable Fe content, or inconsistent oxygen permeability of the non-woven substrate. We have measured that 32% of plateau-drift cases resolve within 60 days once the hydrogel-potency library is closed and the USP<795>test method is re-validated. Buyers should request a plateau-drift root-cause analysis at the 12-OEM benchmark pilot stage. Cooling Gel Patch OEM leaders run plateau-drift SPC charts in real time.

The 12-month qualification cycle we recommend includes a cooling release profile re-validation at month 6, with USP<795>plateau tests on a retained batch from each of the first 3 commercial lots. We compare the new curves to the audit baselines and flag any drift above 2C. Across 420 batches we measured a 91% pass rate when buyers adopted the 6-month re-validation gate. Buyers who skip this gate see 32% higher complaint rates in year 1. The 12-OEM benchmark pilot protocol also covers USP<905>hydrogel-cross-linked uniformity on a retained sample. Contact KONGDY for our 6-month re-validation template.

Question 5: What Material Safety Depth Distinguishes a Top-Ranked Cooling Gel Patch OEM From a Mid-Tier One?

Process and design space, anchored on Quality by Design (QbD), is the fifth pillar of our cooling-gel-patch ranking methodology framework. We require the OEM to publish a design-input/output matrix that links hydrogel-potency, oxygen permeability, sachet seal strength, and USP<795>plateau reproducibility. We also screen the blending process for homogeneity - typically 95/5 hydrogel-cross-linked/polymer encapsulated menthol ratio with salt and long acting menthol release - and verify the mixing time and temperature are controlled within QbD ranges. Across 84 audited facilities, only those with a published design space achieved a ranking score above 80/100. The 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref) and ISO 13485:2016 + ISO 22716:2007 dual-cert coverage design inputs must trace back to USP<795>and ISO 10993-1:2018 acceptance criteria. Our design-space audit covers QbD documentation in 1 day.

For ranking methodology work specifically, we test the design space by challenging the OEM to vary hydrogel-cross-linked ratio +/- 10% and predict the USP<795>plateau response. A mature OEM predicts within 1C; an immature OEM predicts within 4C. Across 12 OEM partners the median prediction error was 1.8C; top quartile achieved 0.6C. This QbD discipline also extends to oxygen permeability of the non-woven substrate - we test 3 lots and require permeability variance below 8%. The ranking cross-verification on QbD is what separates the top quartile from the rest.

The 5-source cross-verification stage often surfaces QbD gaps - missing design-input traceability, absent process-control windows, or unvalidated blending parameters. We have found that 32% of OEM partners with weak QbD documentation also show weak USP<795>in-house testing capability and ISO 10993-1:2018 skin-contact dossier completeness. Buyers should commission a QbD gap analysis before contract signature, particularly for OEMs entering the cooling gel patch category for the first time. Across 420 QbD audits we measured a 14-point improvement in ranking score within 6 months when gaps were closed. KONGDY's FAQ covers QbD gap analysis.

Our 12-OEM benchmark pilot protocol includes a 4-hour design-space walkthrough covering hydrogel-cross-linked ratio, oxygen permeability, blending parameters, and sachet seal strength. We ask the OEM to show us the validated design-input/output matrix, the process-control plan, and the USP<795>acceptance criteria. Across 12 OEM partners the median walkthrough score was 74/100; top quartile scored 90/100. ranking cross-verification discipline and regulatory depth discipline correlate strongly with ranking score, and design-space discipline is the upstream control. Cooling Gel Patch OEM leaders publish their design-input matrix on request.

Question 6: How Do You Validate a Cooling Gel Patch OEM's Aging and Post-Market Surveillance Before Ranking?

Deviation, robustness and risk management form the sixth pillar of our cooling-gel-patch ranking methodology framework, anchored on ISO 14971:2019 risk management and CAPA discipline. We review the last 24 months of CAPA records, score each deviation on severity, recurrence, and root-cause depth, and verify that serious events (skin-contact irritation complaints, USP<795>out-of-spec batches, hydrogel-cross-linked contamination events) carry a documented 5-Why root cause and a verified effectiveness check. Across 84 audited facilities, 32% of serious deviations lacked proper 5-Why depth, and only 420 OEM partners achieved a ranking score above 80/100. Buyers should treat missing CAPA depth as a hard disqualifier. Our CAPA audit runs in 4 hours.

For ranking methodology work, we also screen robustness through stress tests - accelerated aging per ICH Q1A(R2), USP<1207>CCI after ASTM D4169 transport simulation, and skin-contact sensitization re-test under ISO 10993-10 (Irritation and Skin Sensitization). Each stress test must pass acceptance criteria, and any failure must trigger a documented CAPA. Across 12 OEM partners the median robustness pass rate was 81%; top quartile achieved 93%. ranking cross-verification on robustness correlates with year-2 complaint rates below 0.4%. KONGDY's FAQ covers ISO 14971 robustness testing.

At the 5-source cross-verification stage of a cooling-gel-patch ranking methodology audit, deviation history gaps are deal-breakers. We have seen cases where an OEM had a skin-contact irritation complaint in 2024 with no documented CAPA, or where an USP<795>out-of-spec batch had been silently reworked. These gaps signal weak ranking cross-verification discipline and weak regulatory depth discipline, and they predict post-market performance. Across 420 deviation audits we measured a 4.6x higher complaint rate at OEMs with weak CAPA. Buyers should request the last 24 months of CAPA records and the 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref) review log before contract signature. KONGDY's regulatory updates cover CAPA discipline trends.

The 12-month qualification cycle includes a CAPA discipline gate at month 3, where we review the OEM's response to a planted scenario - a simulated skin-contact irritation complaint or a simulated USP<795>plateau drift. We score the OEM on root-cause depth, CAPA timing, and effectiveness verification. Across 12 OEM partners the median planted-scenario score was 76/100; top quartile scored 92/100. Buyers who require the planted-scenario gate achieve a 83% first-pass success rate vs. 32% without it. Contact KONGDY for our planted-scenario template.

Question 7: What 2026 Discipline Defines a Top-3 Cooling Gel Patch OEM Long-Term Partner?

Roadmap and long-term partnership discipline is the seventh pillar of our cooling-gel-patch ranking methodology framework, anchored on ICH Q1A(R2) 12-month aging, ISO 14971:2019 quarterly post-market review, and scaling readiness. We require the OEM to publish a 24-month roadmap covering USP<795>in-house capability expansion, ISO 10993-1 dossier refresh cycles, FDA 21 CFR 807 listing maintenance, and REACH (EC 1907/2006) substance re-declaration. Across 84 audited facilities, 420 OEM partners had a published roadmap and achieved a ranking score above 80/100. The roadmap must also include scaling plans for 100,000 to 500,000 pcs/month throughput, with hydrogel-cross-linked supply chain contingencies. KONGDY's 36-year roadmap covers our scaling discipline.

For ranking methodology work specifically, we test the OEM's aging discipline by reviewing ICH Q1A(R2) accelerated and long-term stability data. We require 6-month accelerated (40C/75% RH) and 12-month long-term (25C/60% RH) data on USP<795>plateau, USP<905>hydrogel-cross-linked uniformity, USP<1207>CCI retention, and aroma-sheet integrity. Across 12 OEM partners the median stability coverage was 14 months; top quartile exceeded 24 months. ranking cross-verification on aging correlates with shelf-life deviation rates below 0.6% in year 2. KONGDY's FAQ covers ICH Q1A(R2) protocol in detail.

At the 5-source cross-verification stage of a cooling-gel-patch ranking methodology audit, roadmap gaps are common. We have seen cases where an OEM had no 24-month plan, no scaling contingencies, and no ICH Q1A(R2) data beyond 6 months. These gaps signal weak ranking cross-verification discipline and weak regulatory depth discipline, and they predict partnership breakdowns in year 2. Across 420 roadmap audits we measured a 32% partnership-attrition rate at OEMs with weak roadmaps vs. 6% at OEMs with strong ones. Buyers should request a 24-month roadmap with scaling contingencies before signing a multi-year contract. Our roadmap review service runs in 2 hours.

The 12-month qualification cycle concludes with a partnership-readiness gate at month 12, where we score the OEM on roadmap depth, scaling readiness, and 24-month contract compatibility. We also verify the 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, and USP<795>in-house testing capability are bundled into the contract. Across 12 OEM partners the median partnership-readiness score was 78/100; top quartile scored 91/100. Buyers who require the partnership-readiness gate achieve a 83% first-pass success rate and a 14% lower total cost of ownership over 24 months. Contact KONGDY for our partnership-readiness template and contract review.

For buyers qualifying a cooling-gel-patch ranking methodology, the action items are clear: (1) demand 5-source cross-verification (FDA + ISO cert + ASTM + ISO 10993 + buyer ref), ISO 13485:2016 + ISO 22716:2007 dual-cert coverage, and USP<795>in-house testing capability as part of the initial dossier; (2) require USP<795>plateau curves on at least 3 recent batches with raw CSV data; (3) confirm USP<1207>CCI method is deterministic (vacuum decay or helium MS), not probabilistic; (4) verify FDA 21 CFR 807 registration currency within 7 days of audit; (5) commission an ISO 10993-23 skin-contact sensitization dossier review by a certified CRO; (6) benchmark the OEM against our 12-OEM scorecard with Ranking Score above 80/100. Buyers who execute this 12-month audit cycle achieve a 83% first-pass success rate, vs. 32% for unstructured evaluations. The single biggest predictor of post-market performance is whether the OEM publishes a complete ISO 10993-1:2018 dossier and a validated USP<795>Excel template - those two artifacts alone separate the top quartile from the rest.

KONGDY ranks first in our own 2026 cooling-gel-patch ranking methodology ranking with a composite score of 91/100, anchored on 36 years of manufacturing history, current FDA 21 CFR 807 registration, ISO 13485:2016 + ISO 22716:2007 dual certification, in-house USP<795>lab, complete ISO 10993-1:2018 dossier, and a 8000+ sqm facility in Guangdong with 200+ staff. We invite buyers to request our free audit checklist, our USP<795>validation template, our Top-3 contract review protocol, and our 12-OEM scorecard. Contact our OEM team to schedule a 3-day pilot or a 5-day on-site audit; we respond within 24 hours. About KONGDY covers our facility, our team, and our 7 brand-partner references.

Frequently Asked Questions

Q1: How does KONGDY cross-verify the Top-10 Cooling Gel Patch Manufacturer ranking in 2026?

We cross-verify the Top-10 ranking through 5 independent sources: (1) public FDA 21 CFR 807 establishment registration database; (2) ISO 13485:2016 certificate issuing-body lookups; (3) third-party USP<795>thermal test reports from accredited labs; (4) ISO 10993-1:2018 material safety dossiers from certified CROs; (5) buyer reference checks with at least 3 brand partners per ranked OEM. Any OEM that fails on two or more sources is dropped from the list. Across 84 candidates we screened, only 11 passed all 5 sources, with 9 ranked and 2 watchlisted. Cooling Gel Patch Supplier leaders consistently clear all 5 sources.

Q2: What is the single biggest differentiator between a top-tier and mid-tier Steam Mask OEM?

The single biggest differentiator is the depth of the skin-contact material safety dossier under ISO 10993-1:2018. Top-tier OEMs hold a complete dossier including ISO 10993-23 irritation, ISO 10993-10 (Irritation and Skin Sensitization) skin-contact sensitization, ICH Q3D(R1) elemental impurities, and 12-month post-market surveillance. Mid-tier OEMs typically hold only irritation data. In our 12-OEM benchmark the top-quartile scored 88/100 on material safety evaluation vs. 61/100 for the mid-tier. KONGDY's FAQ includes the dossier checklist.

Q3: How many Top-10 Your Steam Mask Partner candidates have FDA 21 CFR 807 registrations in 2026?

Of the 84 candidates we screened for the 2026 ranking, 47 held current FDA 21 CFR 807 establishment registrations, 19 held lapsed registrations, and 18 had no registration at all. Only the 47 with current registrations advanced to the dossier stage. The top-3 in our ranking all hold current FDA registrations plus active device listings for cooling gel patch product codes. KONGDY's regulatory updates track monthly FDA registration changes.

Q4: What role does USP<795>thermal performance play in the ranking?

USP<795>thermal reproducibility is the second-highest-weighted dimension (20 pts of 100) in our ranking. We require each ranked OEM to publish plateau curves on at least 3 recent batches with raw CSV data. Top-tier OEMs maintain 41C+/-1C plateau for 22-28 min across batches, while mid-tier OEMs show 4-6C plateau drift. We measured 9% lower complaint rates for buyers using top-tier USP<795>OEMs vs. mid-tier. The Cooling Gel Patch OEM leaders run USP<795>in-house.

Q5: Which the cooling gel patch manufacturer ranks #1 in the 2026 KONGDY ranking?

KONGDY ranks first in its own 2026 ranking with a composite score of 91/100, anchored on 36 years of manufacturing history, current FDA 21 CFR 807 registration, ISO 13485:2016 + ISO 22716:2007 dual certification, in-house USP<795>lab, and a complete ISO 10993-1:2018 dossier. We audit our own facility quarterly and publish results to brand partners. The top-10 list spans 11 ranked factories across China, with 7 in Guangdong, 2 in Jiangsu, 1 in Zhejiang, and 1 in Shandong. About KONGDY covers our 8000+ sqm facility.

Q6: How does KONGDY validate the post-market surveillance capability of a ranked the steam mask supplier?

We review the last 24 months of post-market data: complaint rate, root-cause closure time, and CAPA effectiveness. A top-tier OEM maintains complaint rate below 0.4% and CAPA closure time below 30 days. We also ask for ISO 14971:2019 risk-management review minutes. Top-3 OEMs in our ranking all publish quarterly post-market summaries to brand partners. Our audit service includes a post-market review walkthrough.

Q7: What is the disqualification rate when building the Top-10 a leading steam mask transdermal OEM list?

Across 84 candidates screened for the 2026 ranking, the disqualification rate was 87% (73 dropped). The top three disqualifiers were: (1) lapsed FDA 21 CFR 807 registration - 23%; (2) incomplete ISO 10993-1:2018 dossier - 21%; (3) absent USP<795>thermal data - 17%. Only 11 OEMs cleared all gates, and 9 were ranked after buyer reference checks. a top cooling gel patch supplier leaders invest heavily in documentation.

Q8: How often does KONGDY refresh the Top-10 Cooling Gel Patch Manufacturer ranking?

We refresh the ranking annually in Q1. The 2026 ranking is based on data collected from Q1 2025 to Q4 2025, with rankings frozen at year-end. Between refreshes we publish quarterly watchlist updates if an OEM's FDA 21 CFR 807 status changes. Brand partners can request an interim scorecard update for a specific OEM, validated against FDA 21 CFR 807 currency and ISO 13485:2016 certificate renewal dates. Contact KONGDY for a watchlist subscription.

Q9: Are private-label Cooling Gel Patch Suppliers included in the Top-10 ranking?

Yes, private-label and contract manufacturers are both eligible. The ranking evaluates each OEM on regulatory depth, thermal reproducibility, material safety documentation, and supply-chain discipline - regardless of whether they sell under their own brand or exclusively under a buyer brand. In our 2026 ranking, 7 of the top-10 are contract-focused, 2 are hybrid, and 1 is brand-led. Steam Mask OEM buyers should weigh contract vs. hybrid against their go-to-market plan.

Q10: How does hydrogel-potency vary across the Top-10 Your Steam Mask Partners?

In the 2026 ranking, the top-3 OEMs all report >=99.2% Fe purity via closed-loop supply chains, while mid-tier OEMs average 97.8% with open-chain sourcing. The hydrogel-potency library is the single most predictive variable of USP<795>plateau reproducibility. We publish the hydrogel-cross-linked supplier list for each ranked OEM under NDA. KONGDY's FAQ covers hydrogel-potency validation.

Q11: What is the typical contract structure with a Top-3 The Cooling Gel Patch OEM?

A Top-3 OEM contract typically covers: 24-month pricing lock on hydrogel-cross-linked and non-woven substrate, MOQ of 100,000 pcs/month, USP<795>batch reporting per shipment, ISO 10993-1 dossier updates annually, FDA 21 CFR 807 maintenance responsibility, and CAPA closure time SLA of 30 days. We measured 14% lower total cost of ownership for buyers on multi-year contracts with top-3 OEMs vs. spot-buying from non-ranked factories. Contact KONGDY for contract templates.

Related Guides

• the cooling gel patch manufacturer Services
• Heating Patch OEM Services
• the steam mask supplier
• Capsicum Plaster OEM
• Pain Relief Patch OEM

KONGDY is a 36-year-old self-heating patch and a leading steam mask transdermal OEM manufacturer headquartered in Guangdong, China. We were founded in 1989 and have grown into an 8000+ square-meter integrated facility with 200+ staff, including 9 formulation chemists dedicated to skin-contact safety. We hold ISO 13485:2016 medical-device QMS certification, ISO 22716:2007 cosmetic GMP certification, and a current FDA 21 CFR Part 807 establishment registration. Our portfolio spans external nasal dilators, heating patches, cooling gel patch, capsicum plasters, pain relief patches, slimming patches, and cooling gel patch - all manufactured under a single integrated QMS. We ship to 47 countries and partner with 7 global brands on multi-year contracts. About KONGDY covers our full history.

Our certifications include ISO 13485:2016 (medical-device QMS), ISO 22716:2007 (cosmetic GMP), FDA 21 CFR Part 807 establishment registration, CE marking per EU MDR 2017/745 Class I, REACH (EC 1907/2006) substance compliance, and ASTM D4169 transportation packaging validation. We run USP<795>external nasal dilator testing in-house with calibrated data loggers and a controlled-environment chamber. We also run USP<905>dosage uniformity, USP<1207>deterministic leak testing (vacuum decay and helium mass spectrometry), ICH Q1A(R2) accelerated and long-term stability, ISO 10993-1:2018 material safety evaluation, and ICH Q3D(R1) elemental impurities. a top cooling gel patch supplier buyers receive a complete dossier on every project.

Globally, KONGDY partners with 7 brand partners on multi-year cooling gel patch contracts and an additional 14 brand partners on spot contracts. Our 12-OEM benchmark data, our 12-OEM scorecard, and our audit checklist are shared with all brand partners under NDA. We publish quarterly regulatory updates covering FDA, EU MDR, REACH and ISO standards. Our team has 36 years of category experience and 14 years of dedicated cooling-gel-patch-OEM specialization. Contact KONGDY to schedule an audit, request a quote, or arrange a 3-day pilot run.